These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23163746)

  • 1. In vitro and in vivo studies of galactose-modified liver-targeting liposomes.
    Guo B; Cheng Y; Li N; Li X; Jin M; Li T; Li J
    J Drug Target; 2013 Apr; 21(3):257-264. PubMed ID: 23163746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and characterization of galactose-modified liposomes by a nonaqueous enzymatic reaction.
    Guo BH; Cheng Y; Lin LP; Lin DH; Wu W
    J Liposome Res; 2011 Sep; 21(3):255-60. PubMed ID: 21545336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPLC assay and pharmacokinetics and tissue distribution study of glycyrrhetinic acid liposomes modified with galactosylated lipid.
    Guo BH; Cheng Y; Wu W; Lin LP; Lin DH
    J Liposome Res; 2012 Jun; 22(2):120-7. PubMed ID: 22313057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of liposomal bifendate in liver following intravenous injection in mice.
    Zhipeng C; Jiabi Z; Hongxuan C; Yan-yu X; Jun C; Bao-chang C
    J Drug Target; 2010 Sep; 18(8):627-36. PubMed ID: 20166805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation, Characterization, and Evaluation of Liposomes Containing Oridonin from
    Wang Y; Wang M; Lin F; Zhang X; Zhao Y; Guo C; Wang J
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35164121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galactosylated chitosan nanoparticles for hepatocyte-targeted delivery of oridonin.
    Zheng D; Duan C; Zhang D; Jia L; Liu G; Liu Y; Wang F; Li C; Guo H; Zhang Q
    Int J Pharm; 2012 Oct; 436(1-2):379-86. PubMed ID: 22732673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo studies on the oridonin-loaded nanostructured lipid carriers.
    Zheng D; Dai W; Zhang D; Duan C; Jia L; Liu Y; Zhang Q
    Drug Deliv; 2012 Aug; 19(6):286-91. PubMed ID: 22928767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, characterization, and anti-colon cancer activity of oridonin-loaded long-circulating liposomes.
    Gao C; Zhang L; Tang Z; Fang Z; Ye X; Yu W
    Pharm Dev Technol; 2021 Dec; 26(10):1073-1078. PubMed ID: 34543167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation, Characterization, Pharmacokinetics and Biodistribution of Baicalin-Loaded Liposome on Cerebral Ischemia-Reperfusion after i.v. Administration in Rats.
    Li N; Feng L; Tan Y; Xiang Y; Zhang R; Yang M
    Molecules; 2018 Jul; 23(7):. PubMed ID: 30018228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and characterization of galactosylated bovine serum albumin nanoparticles for liver-targeted delivery of oridonin.
    Li C; Zhang D; Guo H; Hao L; Zheng D; Liu G; Shen J; Tian X; Zhang Q
    Int J Pharm; 2013 May; 448(1):79-86. PubMed ID: 23518367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers.
    Jia L; Shen J; Zhang D; Duan C; Liu G; Zheng D; Tian X; Liu Y; Zhang Q
    Int J Biol Macromol; 2012 Apr; 50(3):523-9. PubMed ID: 22301003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galactosylated bovine serum albumin nanoparticles for parenteral delivery of oridonin: tissue distribution and pharmacokinetic studies.
    Li C; Zhang D; Guo Y; Guo H; Li T; Hao L; Zheng D; Liu G; Zhang Q
    J Microencapsul; 2014; 31(6):573-8. PubMed ID: 24697186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preparation and evaluation of RGD and TAT co-modified paclitaxel loaded liposome].
    Gao B; Mu W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Aug; 39(8):769-74. PubMed ID: 25202944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modifying glycyrrhetinic acid liposomes with liver-targeting ligand of galactosylated derivative: preparation and evaluations.
    Chen J; Chen Y; Cheng Y; Gao Y; Zheng P; Li C; Tong Y; Li Z; Luo W; Chen Z
    Oncotarget; 2017 Nov; 8(60):102046-102066. PubMed ID: 29254224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation, characterization, and pharmacokinetics of oridonin-loaded liposomes.
    Lin FE; Zhang XY; Zhang YP; Wang J
    Biomed Chromatogr; 2023 May; 37(5):e5603. PubMed ID: 36781382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small interfering RNA delivery into the liver by cationic cholesterol derivative-based liposomes.
    Hattori Y; Machida Y; Honda M; Takeuchi N; Yoshiike Y; Ohno H; Onishi H
    J Liposome Res; 2017 Dec; 27(4):264-273. PubMed ID: 27345333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and tissue distribution profile of icariin propylene glycol-liposome intraperitoneal injection in mice.
    Yang W; Yu XC; Chen XY; Zhang L; Lu CT; Zhao YZ
    J Pharm Pharmacol; 2012 Feb; 64(2):190-8. PubMed ID: 22221094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on pharmacokinetics of oridonin in mice].
    Zheng H; Li J; Yao H
    Zhongguo Zhong Yao Za Zhi; 2011 Dec; 36(24):3515-8. PubMed ID: 22368869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of liposomal amiodarone and investigation of its cardiomyocyte-targeting ability in cardiac radiofrequency ablation rat model.
    Zhuge Y; Zheng ZF; Xie MQ; Li L; Wang F; Gao F
    Int J Nanomedicine; 2016; 11():2359-67. PubMed ID: 27313453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo evaluation of mPEG-PLA modified liposomes loaded glycyrrhetinic acid.
    Lu Y; Li J; Wang G
    Int J Pharm; 2008 May; 356(1-2):274-81. PubMed ID: 18304766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.